The Discovery Labs Center for Breakthrough Medicines

Center for Breakthrough Medicines Amplifies Viral Vector Manufacturing Capabilities by Licensing Asimov’s High-Performance GMP Suspension HEK293 Platform

KING OF PRUSSIA, PA — Center for Breakthrough Medicines (CBM) announced a recent agreement with Asimov, a Boston-based mammalian synthetic biology company building tools to design living systems, to license Asimov’s clonal …

Center for Breakthrough Medicines Amplifies Viral Vector Manufacturing Capabilities by Licensing Asimov’s High-Performance GMP Suspension HEK293 Platform Read More